Catalyst for Change: New QA Guidelines Create Opportunities for Innovation

Historically, regulatory compliance has hindered technology and innovation in the life sciences and pharmaceutical industries.

Our podcast explores the latest quality assurance guidance requirements – and the new opportunities those requirements reveal.

Listen to Kevin Thompson and Robb Willman of NTT DATA and Darren Geaney of Kneat Solutions discuss how to drive reduced risk and the acceptance of change in light of changing compliance demands.

What You’ll Learn

  • How regulatory changes and new compliance requirements create opportunities
  • Whether to take a risk-based approach or opportunity-based approach when it comes to new regulations
  • The benefits of focusing quality and assurance efforts around potential impacts to both products and patients